Company Encyclopedia
View More
name
Pro-Dex
PDEX.US
Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. It offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. The company also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries.
1.380 T
PDEX.USMarket value -Rank by Market Cap -/-

Financial Score

13/12/2025 Update
B
Health Care EquipmentIndustry
Industry Ranking36/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreA
    • ROE30.92%A
    • Profit Margin15.94%A
    • Gross Margin28.96%C
  • Growth ScoreA
    • Revenue YoY23.65%A
    • Net Profit YoY114.90%A
    • Total Assets YoY18.40%A
    • Net Assets YoY34.45%A
  • Cash ScoreB
    • Cash Flow Margin627.51%C
    • OCF YoY23.65%A
  • Operating ScoreA
    • Turnover1.18A
  • Debt ScoreB
    • Gearing Ratio35.44%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    CEO van Kirk Jr Acquires 128 Of Pro-Dex Inc [PDEX]

    Pro-Dex Inc's CEO, van Kirk Richard Lee Jr, disclosed changes in ownership via a Form 4 filed with the SEC. On November 20, 2025, he exercised 200 shares and surrendered 72 shares at $30.83 each to cover option exercise costs and tax liabilities. His direct holdings now total 99,707 shares.

    Reuters·
    US
    PDEX
    -0.42%
    Reuters·
    US
    PDEX
    -0.42%

    CFO Charlton Acquires 128 Of Pro-Dex Inc [PDEX]

    Charlton Alisha, CFO of Pro-Dex Inc [PDEX], filed a Form 4 on November 21, 2025, disclosing ownership changes. On 11/20/25, she exercised 200 shares and surrendered 72 shares at $30.83 each, ending with 17,267 direct holdings. The surrender was to cover option exercise costs and/or tax liabilities.

    Reuters·
    US
    PDEX
    -0.42%
    Reuters·
    US
    PDEX
    -0.42%

    Pro-Dex Inc. held annual shareholder meeting

    Pro-Dex Inc. held its 2025 Annual Meeting of Shareholders on November 20, 2025, where shareholders elected Raymond E. Cabillot, Angelita R. Domingo, William J. Farrell III, David C. Hovda, Katrina M.K. Philp, Nicholas J. Swenson, and Richard L. Van Kirk to the board of directors. All nominated candidates were elected.

    Reuters·
    US
    PDEX
    -0.42%
    Reuters·
    US
    PDEX
    -0.42%

    Pro-Dex Reports Strong Earnings Growth in Q3 2025

    Pro-Dex (PDEX) reported strong Q3 2025 earnings, with net sales rising to $18.53 million from $14.89 million year-over-year, and net income nearly doubling to $4.68 million from $2.47 million. The company, specializing in surgical devices, noted significant growth driven by core market performance. Total assets increased to $64.3 million, supported by higher investments and unrealized gains. Pro-Dex maintains a robust balance sheet with increased shareholder equity and reduced liabilities, positioning itself for future growth amid strong market demand for its medical solutions.

    Tip Ranks·
    US
    PDEX
    -0.42%
    Tip Ranks·
    US
    PDEX
    -0.42%

    Pro-Dex (PDEX): One-Off $2.1M Gain Drives Surge in Profit, Challenging Core Growth Narrative

    Pro-Dex (PDEX) reported a net profit margin of 13.5%, significantly up from 4% last year, driven by a one-off $2.1 million gain, resulting in a 322.1% year-over-year profit surge. However, this growth contrasts sharply with the company's 1% annualized earnings growth over the past five years, raising concerns about the sustainability of profits. Pro-Dex's Price-to-Earnings ratio stands at 13.2x, below industry averages, indicating a valuation discount. Investors are advised to consider the long-term growth trend rather than short-term profit spikes.

    Simplywall·
    US
    PDEX
    -0.42%
    Simplywall·
    US
    PDEX
    -0.42%
    © 2025 Longbridge｜Disclaimer